Arunachalam, Prabhu S.
Walls, Alexandra C. http://orcid.org/0000-0002-9636-8330
Golden, Nadia
Atyeo, Caroline
Fischinger, Stephanie http://orcid.org/0000-0003-2307-3379
Li, Chunfeng
Aye, Pyone
Navarro, Mary Jane
Lai, Lilin
Edara, Venkata Viswanadh http://orcid.org/0000-0001-9321-7839
Röltgen, Katharina http://orcid.org/0000-0002-1582-1720
Rogers, Kenneth
Shirreff, Lisa
Ferrell, Douglas E.
Wrenn, Samuel
Pettie, Deleah http://orcid.org/0000-0002-5477-7195
Kraft, John C. http://orcid.org/0000-0002-7931-7478
Miranda, Marcos C.
Kepl, Elizabeth http://orcid.org/0000-0003-2835-003X
Sydeman, Claire
Brunette, Natalie
Murphy, Michael http://orcid.org/0000-0002-8438-2653
Fiala, Brooke
Carter, Lauren
White, Alexander G.
Trisal, Meera
Hsieh, Ching-Lin
Russell-Lodrigue, Kasi http://orcid.org/0000-0003-3719-0779
Monjure, Christopher
Dufour, Jason
Spencer, Skye http://orcid.org/0000-0001-9570-9634
Doyle-Meyers, Lara
Bohm, Rudolph P.
Maness, Nicholas J. http://orcid.org/0000-0002-9332-7891
Roy, Chad http://orcid.org/0000-0002-1710-6974
Plante, Jessica A.
Plante, Kenneth S.
Zhu, Alex http://orcid.org/0000-0003-1712-8310
Gorman, Matthew J.
Shin, Sally http://orcid.org/0000-0002-9306-2264
Shen, Xiaoying
Fontenot, Jane
Gupta, Shakti
O’Hagan, Derek T.
Van Der Most, Robbert
Rappuoli, Rino http://orcid.org/0000-0002-8827-254X
Coffman, Robert L.
Novack, David
McLellan, Jason S. http://orcid.org/0000-0003-3991-542X
Subramaniam, Shankar
Montefiori, David
Boyd, Scott D. http://orcid.org/0000-0003-0963-044X
Flynn, JoAnne L. http://orcid.org/0000-0001-7874-8981
Alter, Galit http://orcid.org/0000-0002-7680-9215
Villinger, Francois
Kleanthous, Harry
Rappaport, Jay
Suthar, Mehul S.
King, Neil P. http://orcid.org/0000-0002-2978-4692
Veesler, David http://orcid.org/0000-0002-6019-8675
Pulendran, Bali http://orcid.org/0000-0001-6517-4333
Article History
Received: 10 February 2021
Accepted: 9 April 2021
First Online: 19 April 2021
Competing interests
: B.P. serves on the External Immunology Board of GlaxoSmithKline, and on the Scientific Advisory Board of Medicago. D.T.O., R.V.D.M. and R.R. are employees of the GSK group of companies. R.L.C. and D.N. are employees of Dynavax Technologies Corporation. H.K. is an employee of Bill and Melinda Gates Foundation. C.-L.H. and J.S.M. are inventors on US patent application no. 63/032,502 ‘Engineered Coronavirus Spike (S) Protein and Methods of Use Thereof’. N.P.K. is a co-founder, shareholder, paid consultant, and chair of the scientific advisory board of Icosavax, Inc. and has received an unrelated sponsored research agreement from Pfizer. D.V. is a consultant for Vir Biotechnology Inc. The Veesler laboratory has received an unrelated sponsored research agreement from Vir Biotechnology Inc.
Free to read: This content has been made available to all.